| For: | Fierro-Angulo OM, González-Regueiro JA, Pereira-García A, Ruiz-Margáin A, Solis-Huerta F, Macías-Rodríguez RU. Hematological abnormalities in liver cirrhosis. World J Hepatol 2024; 16(9): 1229-1246 [PMID: 39351511 DOI: 10.4254/wjh.v16.i9.1229] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i9/1229.htm |
| Number | Citing Articles |
| 1 |
S. Schof, J. Hertzberg, A. Jahnke, Christoph G. Birngruber. Exsanguination from an arteriovenous dialysis fistula: accident, suicide or medical malpractice?. Forensic Science, Medicine and Pathology 2025; 21(2) doi: 10.1007/s12024-025-00955-3
|
| 2 |
Mohammed Abdulrasak, Ali M. Someili, Mostafa Mohrag. Cytopenias in Autoimmune Liver Diseases—A Review. Journal of Clinical Medicine 2025; 14(5) doi: 10.3390/jcm14051732
|
| 3 |
Sulbha Magar, Pratibha Salkar, Kinjal Makani, Jui Dave. Clinical Correlation of Cardiac Dysfunction with Severity of Liver Disease in Liver Cirrhosis Patients: A Hospital-Based Cross-Sectional Observational Study. International Journal of Health Sciences and Research 2026; doi: 10.52403/ijhsr.20260434
|
| 4 |
E. О. Liusina, N. A. Suvorova, A. Р. Kostikov. Spur-cell anemia in patient with acute-on-chronic liver failure: clinical case. Sechenov Medical Journal 2025; 16(3) doi: 10.47093/2218-7332.2025.16.3.48-55
|
| 5 |
Elda Victoria Rodríguez-Negrete, Lourdes Andrea Arriaga Pizano, Karina Sánchez-Reyes, Liliana Anguiano-Robledo, Ángel Morales-González, Raúl Rojas-Martínez, Eduardo Osiris Madrigal-Santillán, José Antonio Morales-González. Cytopenias in Compensated Versus Decompensated Liver Function: Is There a Difference?. Gastroenterology Insights 2025; 16(4) doi: 10.3390/gastroent16040044
|
| 6 |
Massimo Franchini, Pier Mannuccio Mannucci. Coagulation Abnormalities in Chronic Liver Disease. Seminars in Thrombosis and Hemostasis 2026; 52(03) doi: 10.1055/a-2531-4712
|
| 7 |
Kommuri Siddhardha, S. Jalaludheen, Senthil Kumar Aiyappan. Diagnostic Utility of Apparent Diffusion Coefficient Values of Spleen and Liver in Assessment of Severity of Portal Hypertension and Liver Cirrhosis. Nigerian Postgraduate Medical Journal 2026; 33(1) doi: 10.4103/npmj.npmj_333_25
|
| 8 |
Piotr F. Czempik, Michał Gałuszewski, Jan Olszewski, Seweryn Kaczara. Hemostasis in Liver Disease Within Patient Blood Management: A Scoping Review of the Current Literature. Journal of Clinical Medicine 2026; 15(9) doi: 10.3390/jcm15093296
|
| 9 |
Shun Zhang, Rui Liu, Zhengjie Li, Tao Pan, Xudong Wen, Sona Frankova. Predicting short-term mortality in severe cirrhosis: An interpretable machine learning model integrating routine clinical indicators. PLOS One 2026; 21(3) doi: 10.1371/journal.pone.0328952
|
| 10 |
Mohammad Mersad Mansouri Tehrani, Nasser Bahari, Kian Goudarzi, Faeze Salahshour, Babak Shekarchi, Mohammad Masih Mansouri‐Tehrani, Majid Nouri. Can “Attenuation Subtraction”, a Computed Tomography Scan‐Based Factor, be Used as a Predictor of High‐Risk Esophageal Varices in Cirrhotic Patients? A Retrospective Cohort Study. Health Science Reports 2025; 8(5) doi: 10.1002/hsr2.70840
|
| 11 |
Masoud Faghieh Dinavari, Samaneh Abbasian, Amirreza Jabbaripour Sarmadian, Tahereh Vaezi, Tayyebeh Vaezi, Zeinab Nikniaz, Ali Riazi. Multi-strain synbiotic and lifestyle modifications on patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a randomized double-blinded placebo-controlled trial. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-03901-3
|
| 12 |
Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang. Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C. Clinical and Molecular Hepatology 2025; 31(2) doi: 10.3350/cmh.2024.0904
|
| 13 |
Jiayi Chen, Han Yan, Linghua Pei. The J-shaped association between the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and all-cause mortality in patients with cardiometabolic multimorbidity: A retrospective cohort study. Medicine 2026; 105(16) doi: 10.1097/MD.0000000000048148
|
| 14 |
Tayyaba Wali, Saima Ejaz, Shan e Zahra, Mian Abdur Rehman Arif, Fatma Hussain, Muhammad Shahid, Muafia Baigum, Atiqa Nudrat, Fariha Naz, Saadiya Zia. miR-195 mimic, a new therapeutic strategy for suppressing CDK6 expression and progression of hepatocellular carcinoma: a pilot study. Arab Journal of Gastroenterology 2026; 27(2) doi: 10.1016/j.ajg.2026.03.003
|
| 15 |
Wilfredo J Javier-Rojas, Alvin B Newman-Caro, Yizhi Lin, Carlos Montero. Simultaneous Onset of Acute Myeloid Leukemia and Decompensated Cirrhosis: A Rare Case. Cureus 2025; doi: 10.7759/cureus.86990
|
| 16 |
Xian-Bo Wang, Ying Feng, Yong-Qi Li, Zhuo-Jun Li, Yan-Qiu Li. Machine learning-based prediction models for liver-related events in patients with hepatitis B-related cirrhosis and clinically significant portal hypertension. World Journal of Gastroenterology 2026; 32(4): 113492 doi: 10.3748/wjg.v32.i4.113492
Abstract(68) |
Core Tip(67) |
Full Article(HTML)(369)
|
Full Article (PDF)-4632K(230)
|
Full Article with Cover (PDF)-4929K(117)
|
Full Article (XML)-174K(52)
|
Audio-1024K(9)
|
Peer-Review Report-262K(39)
|
Answering Reviewers-329K(60)
|
Supplementary Material-155K(36)
|
Times Cited (0)
|
Total Visits (878)
|
Open
|
| 17 |
Jianchun Wei, Xinjie Huang, Zhilian Wang, Hailing Zhang, Mehmet Baysal. Dynamic platelet profiles in the emergency department and their predictive value for 28-day all-cause mortality in septic patients. PLOS One 2026; 21(5) doi: 10.1371/journal.pone.0348282
|
| 18 |
Thomas Salmon, Gregory Y. H. Lip. Oral anticoagulation therapy in the setting of liver disease. Expert Opinion on Pharmacotherapy 2025; 26(16) doi: 10.1080/14656566.2025.2580358
|
| 19 |
Kristina Baktikulova, Saulesh Kurmangaliyeva, Zamza Khairullina, Kairat Kurmangaliyev, Konstantin Tissin. Role of Erythrocyte Phosphatidylserine Externalization in Anemia among Patients with Hepatitis B Virus- and Hepatitis C Virus-related Cirrhosis. West Kazakhstan Medical Journal 2026; 67(5) doi: 10.4103/wkmj.wkmj_26_26
|
| 20 |
Subhadip Choudhuri, Nisha Jain Garg. Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders. Liver International 2025; 45(6) doi: 10.1111/liv.16245
|
| 21 |
Wenling Wang, Xiaolin Wang, Yu Wu, Huaibin Zou, Manman Xu, Yu Chen. Risk factors for the development of cirrhosis within 1-year in non-cirrhotic patients with HBV- related acute-on-chronic liver failure. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1743728
|
| 22 |
Saravanan Sampoornam Pape Reddy, Delfin Lovelina Francis, Ruchi Harish, Kumara Raja, Sukhbir Singh Chopra. “Liver Clots” in Periodontology: A 10‐Year Clinical Experience. Oral Diseases 2025; 31(4) doi: 10.1111/odi.15190
|
| 23 |
Fengwei Yao, Ji Luo, Qian Zhou, Luhua Wang, Zhijun He. Development and validation of a machine learning-based prediction model for hepatorenal syndrome in liver cirrhosis patients using MIMIC-IV and eICU databases. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-86674-9
|
| 24 |
Dante Pio Pallotta, Francesco Tovoli, Elisa Barbaro, Andrea De Sinno, Matteo Cappelli Aimone Chiorat, Ernestina Santangeli, Fabio Piscaglia. Beyond the Liver: A Systematic Symptom-Based Approach to Extrahepatic Manifestations in Autoimmune Hepatitis. Livers 2026; 6(2) doi: 10.3390/livers6020032
|